510(k) · Cleared
ClearedIno Therapeutics Inoblender, Model 10004
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ino Therapeutics · MRO Apparatus, Nitric Oxide, Backup Delivery
Cleared on Nov 4, 2005 as substantially equivalent to K011874 (Fadasis Medical, Inc., 2001) and 1 other predicate after a 38-day review. Its family tree reaches back 2 generations to 2001. 5 of the 29 devices in its family, counting itself, have a Class I recall. 26 later devices descend from it.
- Decided
- Nov 4, 2005
- Review
- 38 days
- Class
- Class II
- Product code
- MRO
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 2 generations to K003665 (2001). 26 later devices descend from it, 2 citing it directly. 5 of the 29 devices in this family, counting this one, have a Class I recall.
- Root · 2 generations backK003665 Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
- 1 generation backK011874 Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
- This deviceK052663 Ino Therapeutics Inoblender, Model 10004Ino Therapeutics · 2005
- Descendant · cites it directly · 24 of its ownK061901 Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · Recalled
- Descendant · 2 generations on · 16 of its ownK092545 Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2010
- Descendant · 2 generations on · 15 of its ownK070867 Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2007
- Descendant · 2 generations on · 14 of its ownK071516 Inomax DSIno Therapeutics, LLC · 2007
- Descendant · 2 generations on · 11 of its ownK093922 Inomax DSIno Therapeutics · 2010 · Recalled
Showing 5 of 26 descendants. See all descendants
Descendants cleared per year
Class I recalls in this family
Most influential descendants
Showing 5 of 26 · See all- K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · cites it directly24descendants
- K092545Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2010 · 2 generations on16descendants
- K070867Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2007 · 2 generations on15descendants
- K071516Inomax DSIno Therapeutics, LLC · 2007 · 2 generations on14descendants
- K093922Inomax DSIno Therapeutics · 2010 · 2 generations on11descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K003665 | Fadassi Medical FM-1 NO Blender | Fadasis Medical, Inc. | 2001 | — |
| −1 | K011874 | Fadasis Medical FM-1 NO Blender | Fadasis Medical, Inc. | 2001 | — |
| 0 (this device) | K052663 | Ino Therapeutics Inoblender, Model 10004 | Ino Therapeutics | 2005 | — |
| +1 | K061901 | Ino Therapeutics Inomax DS (Delivery System), Model 10003 | Ino Therapeutics | 2006 | 3 |
| +2 | K092545 | Inomax DS (Delivery System), Model 10003 | Ino Therapeutics, LLC | 2010 | — |
| +2 | K070867 | Inomax DS (Delivery System), Model 10003 | Ino Therapeutics, LLC | 2007 | — |
| +2 | K071516 | Inomax DS | Ino Therapeutics, LLC | 2007 | — |
| +2 | K093922 | Inomax DS | Ino Therapeutics | 2010 | 1 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 2 | 0 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 2 | 0 |
| 2012 | 4 | 0 |
| 2013 | 2 | 0 |
| 2015 | 1 | 0 |
| 2018 | 1 | 1 |
| 2020 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 3 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
5 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K011874 | Fadasis Medical FM-1 NO Blender Our reading of the summary gave K001874, FDA’s number for Peripherally Inserted Central Catheter (Utah Medical Products, Inc.). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “FM-I NO Blender”. | 2001 |
| * | K003665 | Fadassi Medical FM-1 NO BlenderSummary page 1…A 1990 and 1992. The INOblender is substantially equivalent to the Fadassi Medical FM-I NO Blender, which was cleared by FDA with 5 10(k) premarket notification numbers K003665 and K01 1874. Indications for use: The 1NOblender provides user set concentrations of inhaled Nitric Oxide (NO), in a balance of… | 2001 |
What descends from it? (26)
See all 262 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (5 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K171696NOxBOXi Nitric Oxide Delivery SystemPraxair Distribution, Inc. · 2018 · 2 generations on · ◆ in the 2018 descendants bar of FIG. 13 Class I recalls
- K220898NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2022 · 3 generations on · ◆ in the 2022 descendants bar of FIG. 12 Class I recalls
- K201339The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc. · 2020 · 3 generations on · ◆ in the 2020 descendants bar of FIG. 12 Class I recalls
- K231823NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2023 · 4 generations on · ◆ in the 2023 descendants bar of FIG. 12 Class I recalls
- K233251NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2024 · 5 generations on · ◆ in the 2024 descendants bar of FIG. 12 Class I recalls
What does this lineage say?
- The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 4.3 years on median.
- None of the 2 ancestors has a recall.
- Of its descendants, K061901 (Ino Therapeutics, 2006) has gone furthest, with 24 descendants of its own.
How does its category compare?
All MRO devicesMRO Apparatus, Nitric Oxide, Backup Delivery: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MRO
1in 2012
2026 to Oct 25, outlined.
Median 510(k) review, days · MRO
Too few MRO 510(k)s in any year since 2007 to give a median.
Recalls per year · MRO
No recall names MRO since 2007.
Adverse event reports per year · MRO
1in 2019
MAUDE reports naming product code MRO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 2 |
| 2013 | 0 | — | 0 | 2 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The INOblender provides user set concentrations of inhaled Nitric Oxide (NO), in a balance of nitrogen, mixed into a user settable constant flow of oxygen gas that is being delivered to a patient. The intended use for the INOblender is as a back up to a primary nitric oxide delivery system or for short term attended use when a primary delivery device cannot practicably be used. This intended use includes applications within a medical facility and transport outside of a medical facility. The INOblender is not intended for use as a primary NO delivery system for long-term use.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K052663 · printed Nov 5, 2026
Cite this page
510(k) Report. “K052663: Ino Therapeutics Inoblender, Model 10004.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K052663
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026